H47.14
Foster-Kennedy syndrome
Clinical Classification Guidelines
Medical Intelligence & Overview
Foster-Kennedy syndrome is a rare neurological condition characterized by a distinctive combination of symptoms resulting from specific brain and orbital abnormalities. It typically involves progressive vision loss in one eye along with neurological signs, such as loss of sense of smell and increased intracranial pressure. Recognized under the ICD-10 code H47.14, this syndrome often points to an underlying tumor or lesion in the frontal lobe of the brain. Proper diagnosis and management are essential to address the root cause and preserve neurological function.
Causes & Symptoms
Clinical Causes: Benign or malignant tumors in the frontal lobe, especially meningiomas Brain abscess or other space-occupying lesions in the anterior cranial fossa Inflammatory or infectious processes affecting the brain tissues Traumatic brain injury leading to localized swelling or lesions
Key Symptoms: Loss of vision in one eye (usually the eye on the same side as the tumor or lesion) Decreased or lost sense of smell (anosmia) on the same side Papilledema or swelling of the optic disc in the unaffected eye Altered intracranial pressure, which can cause headaches, nausea, or vomiting Possible neurological deficits, such as weakness or altered mental status Signs of increased intracranial pressure, including headaches and vomiting
Diagnostic & Treatment
Diagnosis Path: Diagnosing Foster-Kennedy syndrome involves a comprehensive neurological and ophthalmological assessment. Imaging studies are fundamental, with magnetic resonance imaging (MRI) being the preferred modality to identify lesions or tumors in the frontal lobe and surrounding structures. Additional tests may include visual field testing, skull X-rays, and possibly biopsy of the suspected lesion to determine its nature. Neuro-ophthalmic examination reveals characteristic optic nerve swelling and vision loss patterns, assisting in confirming the diagnosis.
Treatment Protocols: Treatment strategies focus on addressing the underlying cause of the syndrome, often involving surgical removal or reduction of brain tumors or lesions. Medications may be prescribed to manage symptoms such as increased intracranial pressure, including corticosteroids or diuretics. In cases of infection, appropriate antimicrobial therapy is essential. Post-treatment follow-up involves regular imaging and neurological assessments to monitor for recurrence or residual effects. Multidisciplinary management by neurosurgeons, neurologists, and ophthalmologists is crucial for optimal care.
Clinical Advice & FAQs
Billing Guidance
Is H47.14 a billable ICD-10 code?
Yes, H47.14 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report H47.14?
Clinical documentation must specify the nature of Foster-Kennedy syndrome and any associated comorbidities for accurate reporting.
Cite this Clinical Reference